Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here


 

Repligen Corporation board reports share repurchase programme

Thursday, June 19, 2008; Posted: 07:00 AM
Stocks RSS
7 Stocks You Need To Know For Tomorrow -- Free Newsletter
Jun 19, 2008 (M2 EQUITYBITES via COMTEX) -- RGEN | Quote | Chart | News | PowerRating -- The board of directors of Repligen Corporation (Nasdaq:RGEN), a biopharmaceutical company, declared on 18 June a repurchase plan for up to 1,250,000 shares of its common stock.

The company said that it is allowed to repurchase shares from time to time at prevailing prices in the open market or in negotiated transactions off the market.

The shares, of which there are currently 31.2m outstanding, will be repurchased with available cash. The repurchase programme allows for modification and with no specific number of shares, which can be suspended or terminated at any time without prior written notice.

Comments on this story may be sent to admin@m2.com

For full details for RGEN click here.
Morning Coffee with TradingMarkets -- Free Newsletter

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.